Leveraging Cost Modeling to
Bring Cell and Gene Therapies to Market
Presenter:
David Ede
Segment Technology Manager,
Sartorius
David Ede is a biomedical and chemical engineer and has a background in process development and manufacturing for viral vectors. In his current role as segment technology manager at Sartorius, David supports viral-based biotechnology stakeholders and helps bring their bioprocesses from R&D to commercial scale. He focuses on using data-driven insights to make cell and gene therapies affordable to all.
